Paul Matthew Blaney

Title: Paul Matthew Blaney: Innovator in Pharmaceutical Compounds

Introduction

Paul Matthew Blaney is a notable inventor based in Chapel-en-le-Frith, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. His work is essential for advancing treatments for various diseases.

Latest Patents

Blaney holds a patent for compounds that are inhibitors of adrenomedullin receptor subtype 2 (AM). The patent details compounds of the formula (I) and pharmaceutically acceptable salts thereof. These compounds are designed for use in the treatment of diseases modulated by AM, including proliferative diseases such as cancer. The patent also includes pharmaceutical compositions comprising these compounds, methods for preparing them, and intermediates useful in their preparation. He has 1 patent to his name.

Career Highlights

Paul Matthew Blaney is affiliated with The University of Sheffield, where he conducts research and development in pharmaceutical sciences. His work has been instrumental in exploring new therapeutic avenues for treating complex diseases.

Collaborations

Blaney has collaborated with notable colleagues, including Gareth Owain Richards and Timothy Michael Skerry. Their combined expertise enhances the research and development efforts in their field.

Conclusion

Paul Matthew Blaney is a distinguished inventor whose work in pharmaceutical compounds is paving the way for innovative treatments. His contributions are vital for addressing significant health challenges.